Module 1: Translational and PD issues
Module 2: Manufacturing and Scale up issues
Module 3: Commercialization and Regulatory Challenges
Module 4: CART and NK cell Therapy
Modul 5: iPSCs Therapeutics
Module 6: Facility Design
Module 8: Emerging Technologies and Start up companies
Module 1: Clone Development: Lessons learnt and furture directions
Module 2: Downstream and Purification
Module 3: Regulatory and GMP compliance
Module 4: Facility design to meet future demand
Module 5: Business Modality- Challenges and Solutions
Module 6: Emerging technologies and Start up companies
Module 7: Emerging technologies and Start up companies
Module 8: Patent and IP issues